Page 6,751«..1020..6,7506,7516,7526,753..6,7606,770..»

CBR – World's Largest Stem Cell Bank – Applies Two Decades of Experience to Advance Regenerative Medicine

Posted: Published on June 21st, 2012

SAN BRUNO, Calif., June 20, 2012 /PRNewswire/ -- Twenty years ago this month, CBR (Cord Blood Registry) in partnership with the University of Arizona, processed the first cord blood stem cell sample in the world to be stored specifically for family use. Since 1992, the number of conditions treated with cord blood stem cells has greatly expanded, and so has CBR. Today, CBR is the largest family cord blood bank in the world with more than 425,000 samples in storage a population the size of a major city like Miami. What distinguishes the "city of individuals" with newborn stem cells banked at CBR is the exclusive opportunity to participate in a growing number of ground-breaking clinical trials. (Photo: http://photos.prnewswire.com/prnh/20120620/SF27549-INFO) (Logo: http://photos.prnewswire.com/prnh/20120216/AQ54476LOGO) "As the leader and innovator in family banking, we believe every newborn deserves a healthy future and that we have a responsibility to lead the way," said Heather Brown, vice president of scientific & medical affairs at CBR. "Looking back, the creation of our bank allowed families for the first time to preserve a genetically-related source of newborn stem cells, ready and available if needed for a lifesaving transplant to regenerate a person's immune system after radiation or chemotherapy. … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on CBR – World's Largest Stem Cell Bank – Applies Two Decades of Experience to Advance Regenerative Medicine

Rudimentary liver grown in vitro

Posted: Published on June 21st, 2012

Japanese scientists have used induced stem cells to create a liver-like tissue in a dish. Although they have yet to publish their results and much work remains to be done, the achievement could have big clinical implications. If the results bear out, they would also constitute a significant advance in the ability to coax stem cells to self-organize into organs. Induced pluripotent stem cells could be a useful source of human organs such as livers. STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY The work was presented by Takanori Takebe, a stem-cell biologist at Yokohama City University in Japan, at the annual meeting of the International Society for Stem Cell Research in Yokohama last week. It blew my mind, said George Daley, director of the stem-cell transplantation programme at the Boston Childrens Hospital in Massachusetts, who chaired the session. It sounds like a genuine advance, says Stuart Forbes, who studies liver regeneration at the University of Edinburgh, UK. Forbes, who also works as a consultant for Scotlands liver-transplantation unit, says that the advance could one day help to avoid the bleak outcome currently experienced by the many patients who dont survive long enough to get a new liver. But the liver described by Takebe … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Rudimentary liver grown in vitro

Rudimentary Liver Grown in the Lab

Posted: Published on June 21st, 2012

Image: NASA, Johnson Space Center From Nature magazine Japanese scientists have used induced stem cells to create a liver-like tissue in a dish. Although they have yet to publish their results and much work remains to be done, the achievement could have big clinical implications. If the results bear out, they would also constitute a significant advance in the ability to coax stem cells to self-organize into organs. The work was presented by Takanori Takebe, a stem-cell biologist at Yokohama City University in Japan, at the annual meeting of the International Society for Stem Cell Research in Yokohama last week. It blew my mind, said George Daley, director of the stem-cell transplantation programme at the Boston Childrens Hospital in Massachusetts, who chaired the session. It sounds like a genuine advance, says Stuart Forbes, who studies liver regeneration at the University of Edinburgh, UK. Forbes, who also works as a consultant for Scotlands liver-transplantation unit, says that the advance could one day help to avoid the bleak outcome currently experienced by the many patients who dont survive long enough to get a new liver. But the liver described by Takebe has a long way to go before that. Takebe told how … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Rudimentary Liver Grown in the Lab

Anchoring points determine fate of stem cells

Posted: Published on June 21st, 2012

Mesenchymal Stem Cells (hMSCs) cultured on a Polyacrylamide gel for 7 days: Cells stained in blue are ALP positive which is a marker for osteogenic differentiation, while the cells that contain red oil droplets underwent adipogenic differentiation. Credit: Bojun Li and Prof. Viola Vogel / ETH Zurich (Phys.org) -- Researchers were positive: a substrates softness influences the behaviour of stem cells in culture. Now other researchers have made a new discovery: the number of anchoring points to which the cells can adhere is pivotal. How stem cells differentiate is evidently not so much a question of the stiffness of the substrate upon which they thrive, as the cells mechanical anchoring on the substrate surface. This is shown in a study recently published in Nature Materials by researchers from various European universities, including ETH Zurich. Since 2006 the research community has been convinced that stem cells can feel the softness of materials they grow upon. Scientists mainly drew this conclusion from correlations between the softness of the substrate and the cells behavior. The new research project, to which ETH-Zurich professor Viola Vogel and her doctoral student Bojun Li made a key contribution, has come to another conclusion. It reveals that the … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Anchoring points determine fate of stem cells

LIFE Focuses on Stem Cell Research

Posted: Published on June 20th, 2012

Given the recent flurry of activities, it seems that Life Technologies Corporation (LIFE) is focused on strengthening its foothold in the field of stem cell research. The company recently signed a non-exclusive agreement with iPS Academia of Japan for its induced pluripotent stem (iPS) cell patent portfolio. Based on this agreement, the company will be able to expand its portfolio for the iPS cell research community. Besides, it is well placed to create iPS cells and differentiate them into various cell types to be used in drug discovery and pre-clinical research. The license also enables Life Technologies to provide creation, differentiation and screening services of iPS cell to scientists globally. We consider the agreement to be a significant achievement for the company in the field of stem cell research as iPS cells are gaining attention for use in the areas of drug discovery, disease research and other areas of biotechnology. The agreement with iPS Academia of Japan comes on the heels of the partnership with Cellular Dynamics International, the world's largest producer of human cells derived from iPS cells. The partnership will aim at commercializing a set of three new products optimized to consistently develop and grow human iPS cells … Continue reading

Comments Off on LIFE Focuses on Stem Cell Research

Presentations from the Regenerative Strategies and Emerging Technologies Forum at the American Orthopedic Foot and …

Posted: Published on June 20th, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Numerous presentations were made today during the Regenerative Strategies Forum at the 2012 American Orthopaedic Foot and Ankle Society (AOFAS) annual meeting in San Diego, CA which supported the safety, effectiveness, clinical need, biologic rationale and cost effectiveness of Augment Bone Graft from BioMimetic Therapeutics, Inc. (BMTI). Regenerative Strategies and Emerging Technologies Pre-meeting Presentations The forum included lectures by numerous leading foot and ankle surgeons covering regenerative strategies related to foot and ankle surgery. The following presentations highlighted the clinical and pharmaco-economic need and biologic rationale for Augment Bone Graft as an alternative to autograft. AOFAS Annual Meeting Presentations and Poster In addition to the above presentations given today at the regenerative forum, the following presentations related to the clinical need for Augment or Augment Injectable Bone Graft will be presented later during the AOFAS annual meeting. Exhibit Booth In addition to these surgeon presentations at the AOFAS annual meeting, BioMimetic will host a commercial exhibit booth #401 in the Sapphire Ballroom at the Hilton Bayfront Hotel from June 21 23. About BioMimetic Therapeutics BioMimetic Therapeutics (BMTI) is a biotechnology company specializing in the development and commercialization of clinically proven products to promote the healing of musculoskeletal … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Presentations from the Regenerative Strategies and Emerging Technologies Forum at the American Orthopedic Foot and …

CBR – World's Largest Stem Cell Bank – Applies Two Decades of Experience to Advance Regenerative Medicine

Posted: Published on June 20th, 2012

SAN BRUNO, Calif., June 20, 2012 /PRNewswire/ -- Twenty years ago this month, CBR (Cord Blood Registry) in partnership with the University of Arizona, processed the first cord blood stem cell sample in the world to be stored specifically for family use. Since 1992, the number of conditions treated with cord blood stem cells has greatly expanded, and so has CBR. Today, CBR is the largest family cord blood bank in the world with more than 425,000 samples in storage a population the size of a major city like Miami. What distinguishes the "city of individuals" with newborn stem cells banked at CBR is the exclusive opportunity to participate in a growing number of ground-breaking clinical trials. (Photo: http://photos.prnewswire.com/prnh/20120620/SF27549-INFO) (Logo: http://photos.prnewswire.com/prnh/20120216/AQ54476LOGO) "As the leader and innovator in family banking, we believe every newborn deserves a healthy future and that we have a responsibility to lead the way," said Heather Brown, vice president of scientific & medical affairs at CBR. "Looking back, the creation of our bank allowed families for the first time to preserve a genetically-related source of newborn stem cells, ready and available if needed for a lifesaving transplant to regenerate a person's immune system after radiation or chemotherapy. … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on CBR – World's Largest Stem Cell Bank – Applies Two Decades of Experience to Advance Regenerative Medicine

Rudimentary liver grown in vitro

Posted: Published on June 20th, 2012

Japanese scientists have used induced stem cells to create a liver-like tissue in a dish. Although they have yet to publish their results and much work remains to be done, the achievement could have big clinical implications. If the results bear out, they would also constitute a significant advance in the ability to coax stem cells to self-organize into organs. Induced pluripotent stem cells could be a useful source of human organs such as livers. STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY The work was presented by Takanori Takebe, a stem-cell biologist at Yokohama City University in Japan, at the annual meeting of the International Society for Stem Cell Research in Yokohama last week. It blew my mind, said George Daley, director of the stem-cell transplantation programme at the Boston Childrens Hospital in Massachusetts, who chaired the session. It sounds like a genuine advance, says Stuart Forbes, who studies liver regeneration at the University of Edinburgh, UK. Forbes, who also works as a consultant for Scotlands liver-transplantation unit, says that the advance could one day help to avoid the bleak outcome currently experienced by the many patients who dont survive long enough to get a new liver. But the liver described by Takebe … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Rudimentary liver grown in vitro

Cell Therapeutics Readies Commercial Launch of Pixuvri® in EU; Re-Alignment of Resources and Portfolio Priorities …

Posted: Published on June 20th, 2012

SEATTLE, June 20, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC), a company focused on translating science into novel cancer therapies, today announced that it is re-aligning its resources and re-prioritizing its product development pipeline to focus on the launch of Pixuvri in the EU and accelerate the advancement of pacritinib, CTI's recently-acquired, highly-selective JAK 2 inhibitor, into phase III clinical trials. As a result, CTI's operating burn rate will be reduced from an average of $6.5 million per month to an average of $4.5 million per month. "In-market research across the five largest EU markets confirms significant physician interest in product adoption in the target patient population. With the potential to generate meaningful Pixuvri product sales, coupled with the recent acquisition of pacritinib and investigator interest in participating in its pivotal studies, we believe that focusing our resources on the Pixuvri launch and accelerating the start of pacritinib phase III studies is the best deployment of our limited resources to build near-term shareholder value," said James A. Bianco, M.D., Chief Executive Officer of CTI. "We are re-evaluating the tostedostat phase III clinical trial design and are considering both studies in a refractory setting and in front … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Cell Therapeutics Readies Commercial Launch of Pixuvri® in EU; Re-Alignment of Resources and Portfolio Priorities …

Rudimentary Liver Grown in the Lab

Posted: Published on June 20th, 2012

Image: NASA, Johnson Space Center From Nature magazine Japanese scientists have used induced stem cells to create a liver-like tissue in a dish. Although they have yet to publish their results and much work remains to be done, the achievement could have big clinical implications. If the results bear out, they would also constitute a significant advance in the ability to coax stem cells to self-organize into organs. The work was presented by Takanori Takebe, a stem-cell biologist at Yokohama City University in Japan, at the annual meeting of the International Society for Stem Cell Research in Yokohama last week. It blew my mind, said George Daley, director of the stem-cell transplantation programme at the Boston Childrens Hospital in Massachusetts, who chaired the session. It sounds like a genuine advance, says Stuart Forbes, who studies liver regeneration at the University of Edinburgh, UK. Forbes, who also works as a consultant for Scotlands liver-transplantation unit, says that the advance could one day help to avoid the bleak outcome currently experienced by the many patients who dont survive long enough to get a new liver. But the liver described by Takebe has a long way to go before that. Takebe told how … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Rudimentary Liver Grown in the Lab

Page 6,751«..1020..6,7506,7516,7526,753..6,7606,770..»